Rexahn Pharmaceuticals, Inc. (REXN)

[DorianGray]

It's a 10k of jibber jabber, but there was some info i hadn't seen in their agreement with Haichang. Didn't we read this trial will have initial results this year? That would be a good indicator if Haichang would potentially exercise their exclusive license. So unless the U.S. Goes to war with China, we may get some funding next year......


Haichang will fund all development activities through completion of the Phase 2a clinical trial up to an aggregate amount of $10,000,000 and the parties will share downstream licensing fees and royalties paid by third parties in an agreed ratio in connection with the further development and commercialization of RX-0201 for the treatment of HCC. If Haichang exercises its right of first negotiation after completion of the Phase 2a clinical trial to obtain an exclusive license to further develop and commercialize RX-0201 in China, Haichang will pay customary license fees, milestone payments and royalties to Rexahn. Any clinical trials conducted by Haichang will be designed to meet both FDA and China Food and Drug Administration requirements.